Why the study?
Metabolic and behavioral disorders represent severe health problems, raising questions about their molecular relationship and the role of adipokines.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
This review discusses the mechanisms by which adipokines and lipogenesis link metabolic disorders like dyslipidemia and insulin resistance with hypertension, oxidative stress, and depression.
Current studies show that metabolic and behavioral disorders represent severe health problems. Several questions arise about the molecular relationship of metabolic and behavioral disorders. This review will discuss the relationship of lipid metabolism and fructose consumption accompanied by an increase in weight as well as associated disorders: hypertension, insulin-resistance, oxidative stress and depression. Adipose tissue is considered as an endocrine tissue with intense secretory activities (metabolic and inflammatory). These adipokines are responsible for an alteration of several physiological functions. In this review we will try to understand how lipogenesis that causes dyslipidemia can influence insulin resistance, hypertension, oxidative stress, depression and the relationship between these various disorders.
No takes yet. Share an insight, caveat, or question.
Chahirou et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: